Clinical Trial Update: Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating treatment of macular holes using plasma rich in growth factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Holes

Snippet

Sponsor: Minia University | Conditions: Macular Holes | Phase 2 | Status: UNKNOWN